SCHEMBL8625523

SCHEMBL8625523

CCCC[Si](C)(C)OCCCC=C(C)CO

nearest known ligand 0.33

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
BTN3A1 O00481 4/20 0.33
CNR2 P34972 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8947046 0.86
SCHEMBL2582810 0.75 ALDH1A1 (0.42)
SCHEMBL10906327 0.74
SCHEMBL15292867 0.74 ADRB2 (0.38)
SCHEMBL8473354 0.74
SCHEMBL8473356 0.74
SCHEMBL2599066 0.74 TSHR (0.48)
SCHEMBL8947094 0.73 BTN3A1 (0.34) BTN3A1
SCHEMBL8849600 0.73 BTN3A1 (0.34) BTN3A1
SCHEMBL8896843 0.73 SMN1; SMN2 (0.44)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5712396-A PHOSPHONOSULFONATE COMPOUNDS USED FOR INHIBITING CHOLESTEROL BIOSYNTHESIS AND ATHEROSCLEROSIS MAGNIN DAVID R (US) 1998-01-27 US disclosed
US-5470845-A Methods of using α-phosphonosulfonate squalene synthetase inhibitors including the treatment of atherosclerosis and hypercholesterolemia BRISTOL-MYERS SQUIBB COMPANY (US) 1995-11-28 US disclosed